Fig. 3

RAI-CROMRIS at baseline and at 6 months in patients treated with bisphosphonates. The distribution of RAI-CROMRIS values (A) and of the extension of bone hyperintensity (B) at baseline and at 6 months in 27 patients who received bisphosphonates with MRI at baseline (T0) and at 6 months (T6) were analysed